Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

Related Articles by Review for PubMed (Select 16995942)

2.

Recent advances in the development of oncolytic HSV-1 vectors: 'arming' of HSV-1 vectors and application of bacterial artificial chromosome technology for their construction.

Jeyaretna DS, Kuroda T.

Curr Opin Mol Ther. 2007 Oct;9(5):447-66. Review. Erratum in: Curr Opin Mol Ther. 2007 Dec;9(6):611.

PMID:
17932809
3.

Oncolytic virus therapy using genetically engineered herpes simplex viruses.

Todo T.

Front Biosci. 2008 Jan 1;13:2060-4. Review.

PMID:
17981691
4.

Oncolytic herpes simplex virus engineering and preparation.

Agarwalla PK, Aghi MK.

Methods Mol Biol. 2012;797:1-19. doi: 10.1007/978-1-61779-340-0_1. Review.

PMID:
21948465
5.
6.

Gene transfer to muscle using herpes simplex virus-based vectors.

Huard J, Krisky D, Oligino T, Marconi P, Day CS, Watkins SC, Glorioso JC.

Neuromuscul Disord. 1997 Jul;7(5):299-313. Review.

PMID:
9267843
7.

Herpes simplex virus-based vectors for the treatment of cancer and neurodegenerative disease.

Latchman DS.

Curr Opin Mol Ther. 2005 Oct;7(5):415-8. Review.

PMID:
16248276
8.

Oncolytic herpes simplex virus therapy for peripheral nerve tumors.

Jeyaretna DS, Rabkin SD, Martuza RL.

Neurosurg Focus. 2007 Jun 15;22(6):E4. Review.

PMID:
17613221
9.

Gene delivery using herpes simplex virus vectors.

Burton EA, Fink DJ, Glorioso JC.

DNA Cell Biol. 2002 Dec;21(12):915-36. Review.

PMID:
12573050
10.

Chimeric herpes simplex virus/adeno-associated virus amplicon vectors.

Glauser DL, Ackermann M, Saydam O, Fraefel C.

Curr Gene Ther. 2006 Jun;6(3):315-24. Review.

PMID:
16787183
11.

Intraperitoneal oncolytic and tumor vaccination therapy with replication-competent recombinant virus: the herpes paradigm.

Coukos G, Courreges MC, Benencia F.

Curr Gene Ther. 2003 Apr;3(2):113-25. Review.

PMID:
12653405
12.

Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system.

Fink DJ, Ramakrishnan R, Marconi P, Goins WF, Holland TC, Glorioso JC.

Clin Neurosci. 1995-1996;3(5):284-91. Review.

PMID:
8914795
13.

Herpes simplex virus type 1 amplicons and their hybrid virus partners, EBV, AAV, and retrovirus.

Oehmig A, Fraefel C, Breakefield XO, Ackermann M.

Curr Gene Ther. 2004 Dec;4(4):385-408. Review.

PMID:
15578989
14.

HSV amplicon vectors for cancer therapy.

Shah K, Breakefield XO.

Curr Gene Ther. 2006 Jun;6(3):361-70. Review.

PMID:
16787187
15.
16.

Herpes simplex virus vectors for gene therapy.

Latchman DS.

Mol Biotechnol. 1994 Oct;2(2):179-95. Review.

PMID:
7866875
17.

Targeted oncolytic herpes simplex viruses for aggressive cancers.

Wong J, Lee C, Zhang K, Rennie PS, Jia W.

Curr Pharm Biotechnol. 2012 Jul;13(9):1786-94. Review.

PMID:
21740360
18.

Advance in herpes simplex viruses for cancer therapy.

Liu S, Dai M, You L, Zhao Y.

Sci China Life Sci. 2013 Apr;56(4):298-305. doi: 10.1007/s11427-013-4466-4. Epub 2013 Apr 7. Review.

PMID:
23564184
19.

Replicating herpes simplex virus vectors for cancer gene therapy.

Yeung SN, Tufaro F.

Expert Opin Pharmacother. 2000 May;1(4):623-31. Review.

PMID:
11249507
20.

HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy.

Epstein AL, Marconi P, Argnani R, Manservigi R.

Curr Gene Ther. 2005 Oct;5(5):445-58. Review.

PMID:
16250886
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk